Stimulus-Responsive Nanodelivery and Release Systems for Cancer Gene Therapy: Efficacy Improvement Strategies

References

• Li X, Le Y. Viral Vector-Based Gene Therapy. Int J Mol Sci. 2023;24(9):7736. doi:10.3390/ijms24097736
   PubMed Web of Science ®Google Scholar
• Hald Albertsen C, Kulkarni JA, Witzigmann D, et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416. doi:10.1016/j.addr.2022.114416
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Q, Zhang X, et al. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J Nanobiotechnology. 2022;20(1):279. doi:10.1186/s12951-022-01472-z
   PubMed Web of Science ®Google Scholar
• Maurer MS, Kale P, Fontana M, et al. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med. 2023;389(17):1553–1565. doi:10.1056/NEJMoa2300757
   PubMed Web of Science ®Google Scholar
• Cao S, Lin C, Li X, et al. TME-responsive multistage nanoplatform for siRNA delivery and effective cancer therapy. Int J Nanomed. 2021;16:5909–5921. doi:10.2147/ijn.s322901
   PubMedGoogle Scholar
• Wang Y, Wang C, Sylvers J, et al. Nanoenhancer for improving naked DNA electrotransfection In vivo. Front Bioeng Biotechnol. 2023;11:1181795. doi:10.3389/fbioe.2023.1181795
   PubMed Web of Science ®Google Scholar
• Ling Q, Herstine JA, Bradbury A, Gray SJ. AAV-based in vivo gene therapy for neurological disorders. Nat Rev Drug Discov. 2023;22(10):789–806. doi:10.1038/s41573-023-00766-7
   PubMed Web of Science ®Google Scholar
• Lundstrom K. Viral vectors in gene therapy: where do we stand in 2023? Viruses. 2023;15(3):698. doi:10.3390/v15030698
   PubMed Web of Science ®Google Scholar
• Malina J, Kostrhunova H, Novohradsky V, et al. Metallohelix vectors for efficient gene delivery via cationic DNA nanoparticles. Nucleic Acids Res. 2022;50(2):674–683. doi:10.1093/nar/gkab1277
   PubMed Web of Science ®Google Scholar
• Mao H, Angela S, Stephan T, et al. Stimulus-responsive assembly of nonviral nucleocapsids. Nat Commun. 2024;15(1):3576. doi:10.1038/s41467-024-47808-1
   PubMed Web of Science ®Google Scholar
• Wang C, Pan C, Yong H, et al. Emerging non-viral vectors for gene delivery. J Nanobiotechnology. 2023;21(1):272. doi:10.1186/s12951-023-02044-5
   PubMed Web of Science ®Google Scholar
• Guo C, Liu Y, Zhao Z, et al. Regulating inflammation and apoptosis: a smart microgel gene delivery system for repairing degenerative nucleus pulposus. J Control Release. 2023;365:1004–1018. doi:10.1016/j.jconrel.2023.12.029
   PubMed Web of Science ®Google Scholar
• Zhang Q, Kuang G, Li W, et al. Stimuli-responsive gene delivery nanocarriers for cancer therapy. Nanomicro Lett. 2023;15(1):44. doi:10.1007/s40820-023-01018-4
   PubMed Web of Science ®Google Scholar
• Yu C, Li L, Hu P, et al. Recent advances in stimulus-responsive nanocarriers for gene therapy. Adv Sci (Weinh). 2021;8(14):2100540. doi:10.1002/advs.202100540
   PubMedGoogle Scholar
• Ji Y, Fan L, Qu S, et al. Stimuli-responsive delivery strategies for controllable gene editing in tumor therapeutics. J Mater Chem B. 2022;10(38):7694–7707. doi:10.1039/d2tb01055k
   PubMed Web of Science ®Google Scholar
• Ma B, Xiao Y, Lv Q, et al. Targeting theranostics of atherosclerosis by dual-responsive nanoplatform via photoacoustic imaging and three-in-one integrated lipid management. Adv Mater. 2023;35(5):e2206129. doi:10.1002/adma.202206129
   PubMed Web of Science ®Google Scholar
• Xie L, Wang J, Song L, et al. Cell-cycle dependent nuclear gene delivery enhances the effects of E-cadherin against tumor invasion and metastasis. Signal Transduct Target Ther. 2023;8(1):182. doi:10.1038/s41392-023-01398-4
   PubMed Web of Science ®Google Scholar
• Arnott S. Historical article: DNA polymorphism and the early history of the double helix. Trends Biochem Sci. 2006;31(6):349–354. doi:10.1016/j.tibs.2006.04.004
   PubMed Web of Science ®Google Scholar
• Kang TH, Park Y, Bader JS, et al. The housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT) regulates multiple developmental and metabolic pathways of murine embryonic stem cell neuronal differentiation. PLoS One. 2013;8(10):e74967. doi:10.1371/journal.pone.0074967
   PubMed Web of Science ®Google Scholar
• Pai SY. Built to last: gene therapy for ADA SCID. Blood. 2021;138(15):1287–1288. doi:10.1182/blood.2021012300
   PubMed Web of Science ®Google Scholar
• Ballow M, Henderson T, Scalchunes C, et al. Seasonal viral influenza among persons with primary antibody immunodeficiency. J Allergy Clin Immunol Pract. 2019;7(3):1058–1060.e1053. doi:10.1016/j.jaip.2018.12.002
   PubMed Web of Science ®Google Scholar
• Barresi V, Musmeci C, Rinaldi A, et al. Transcript-targeted therapy based on RNA interference and antisense oligonucleotides: current applications and novel molecular targets. Int J Mol Sci. 2022;23(16):8875. doi:10.3390/ijms23168875
   PubMed Web of Science ®Google Scholar
• Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 1999;286(5448):2244–2245. doi:10.1126/science.286.5448.2244
   PubMed Web of Science ®Google Scholar
• Braun CJ, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014;6(227):227ra233. doi:10.1126/scitranslmed.3007280
   Web of Science ®Google Scholar
• Zhou S, Fatima S, Ma Z, et al. Evaluating the safety of retroviral vectors based on insertional oncogene activation and blocked differentiation in cultured thymocytes. Mol Ther. 2016;24(6):1090–1099. doi:10.1038/mt.2016.55
   PubMed Web of Science ®Google Scholar
• Pule MN, Glover ML, Fire AZ, et al. Ribosome clearance during RNA interference. RNA. 2019;25(8):963–974. doi:10.1261/rna.070813.119
   PubMed Web of Science ®Google Scholar
• Takkar B, Bansal P, Venkatesh P. Leber’s congenital amaurosis and gene therapy. Indian J Pediatr. 2018;85(3):237–242. doi:10.1007/s12098-017-2394-1
   PubMed Web of Science ®Google Scholar
• Hong M, Li T, Xue W, et al. Genetic engineering of baculovirus-insect cell system to improve protein production. Front Bioeng Biotechnol. 2022;10:994743. doi:10.3389/fbioe.2022.994743
   PubMed Web of Science ®Google Scholar
• Keeler AM, Flotte TR. Recombinant adeno-associated virus gene therapy in light of luxturna (and Zolgensma and Glybera): where are we, and how did we get here? Annu Rev Virol. 2019;6(1):601–621. doi:10.1146/annurev-virology-092818-015530
   PubMedGoogle Scholar
• Hoy SM. Patisiran: first global approval. Drugs. 2018;78(15):1625–1631. doi:10.1007/s40265-018-0983-6
   PubMed Web of Science ®Google Scholar
• Hoy SM. Onasemnogene abeparvovec: first global approval. Drugs. 2019;79(11):1255–1262. doi:10.1007/s40265-019-01162-5
   PubMed Web of Science ®Google Scholar
• Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096. doi:10.1126/science.1258096
   PubMed Web of Science ®Google Scholar
• Li J, Zeng H, Li L, et al. Biomembrane-wrapped gene delivery nanoparticles for cancer therapy. Front Bioeng Biotechnol. 2023;11:1211753. doi:10.3389/fbioe.2023.1211753
   PubMed Web of Science ®Google Scholar
• Zou L, Wang J, Fang Y, et al. PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery. Biomater Res. 2022;26(1):69. doi:10.1186/s40824-022-00322-1
   PubMedGoogle Scholar
• Miao G, He Y, Lai K, et al. Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients. J Control Release. 2023;363:12–26. doi:10.1016/j.jconrel.2023.09.003
   PubMed Web of Science ®Google Scholar
• Sun W, Liu XY, Ma LL, et al. Tumor targeting gene vector for visual tracking of Bcl-2 siRNA transfection and anti-tumor therapy. ACS Appl Mater Interfaces. 2020;12(9):10193–10201. doi:10.1021/acsami.0c00652
   PubMed Web of Science ®Google Scholar
• Sindhwani S, Syed AM, Ngai J. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19(5):566–575. doi:10.1038/s41563-019-0566-2
   PubMed Web of Science ®Google Scholar
• Villari G, Gioelli N, Valdembri D, et al. Vesicle choreographies keep up cell-to-extracellular matrix adhesion dynamics in polarized epithelial and endothelial cells. Matrix Biol. 2022;112:62–71. doi:10.1016/j.matbio.2022.08.003
   PubMed Web of Science ®Google Scholar
• Cai X, Dou R, Guo C, et al. Cationic polymers as transfection reagents for nucleic acid delivery. Pharmaceutics. 2023;15(5):1502. doi:10.3390/pharmaceutics15051502
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Venida A, Yano J, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100–105. doi:10.1038/s41586-020-2229-5
   PubMed Web of Science ®Google Scholar
• Yang Y, Ning H, Xia T, et al. Electrostatic attractive self-delivery of siRNA and Light-Induced Self-Escape for Synergistic Gene Therapy. Adv Mater. 2023;35(30):e2301409. doi:10.1002/adma.202301409
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou Q, Wang G, et al. Effect of cationic charge density on transcytosis of polyethylenimine. Biomacromolecules. 2021;22(12):5139–5150. doi:10.1021/acs.biomac.1c01109
   PubMed Web of Science ®Google Scholar
• Lee J, Kwon YE, Edwards SD, et al. Improved biocompatibility of dendrimer-based gene delivery by histidine-modified nuclear localization signals. Int J Pharm. 2023;644:123299. doi:10.1016/j.ijpharm.2023.123299
   PubMedGoogle Scholar
• Harini K, Srivastava A, Kulandaisamy A, et al. ProNAB: database for binding affinities of protein-nucleic acid complexes and their mutants. Nucleic Acids Res. 2022;50(D1):D1528–d1534. doi:10.1093/nar/gkab848
   PubMed Web of Science ®Google Scholar
• Largy E. Mass spectrometry of nucleic acid noncovalent complexes. Chem Rev. 2022;122(8):7720–7839. doi:10.1021/acs.chemrev.1c00386
   PubMed Web of Science ®Google Scholar
• Klein NP, Lewis N, Goddard K, et al. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021;326(14):1390–1399. doi:10.1001/jama.2021.15072
   PubMed Web of Science ®Google Scholar
• Zhang Z, Mateus J, Coelho CH, et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022;185(14):2434–2451.e2417. doi:10.1016/j.cell.2022.05.022
   PubMed Web of Science ®Google Scholar
• Ertl HCJ. Mitigating serious adverse events in gene therapy with AAV vectors: vector dose and immunosuppression. Drugs. 2023;83(4):287–298. doi:10.1007/s40265-023-01836-1
   PubMed Web of Science ®Google Scholar
• Sato-Dahlman M, LaRocca CJ, Yanagiba C, Yamamoto M. Adenovirus and immunotherapy: advancing cancer treatment by combination. Cancers (Basel). 2020;12(5):1295. doi:10.3390/cancers12051295
   PubMed Web of Science ®Google Scholar
• Yao J, Atasheva S, Wagner N, et al. Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform. Mol Ther. 2024;32(1):103–123. doi:10.1016/j.ymthe.2023.10.023
   PubMed Web of Science ®Google Scholar
• Wang X, Ma C, Rodríguez Labrada R, et al. Recent advances in lentiviral vectors for gene therapy. Sci China Life Sci. 2021;64(11):1842–1857. doi:10.1007/s11427-021-1952-5
   PubMed Web of Science ®Google Scholar
• Toms M, Toualbi L, Almeida PV, et al. Successful large gene augmentation of USH2A with non-viral episomal vectors. Mol Ther. 2023;31(9):2755–2766. doi:10.1016/j.ymthe.2023.06.012
   PubMed Web of Science ®Google Scholar
• Bogaert B, Sauvage F, Guagliardo R, et al. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs. J Control Release. 2022;350:256–270. doi:10.1016/j.jconrel.2022.08.009
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang L, Zhu W, et al. Barriers and strategies of cationic liposomes for cancer gene therapy. Mol Ther Methods Clin Dev. 2020;18:751–764. doi:10.1016/j.omtm.2020.07.015
   PubMed Web of Science ®Google Scholar
• Van Bruggen C, Hexum JK, Tan Z, Dalal RJ, Reineke TM. Nonviral gene delivery with cationic glycopolymers. Acc Chem Res. 2019;52(5):1347–1358. doi:10.1021/acs.accounts.8b00665
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang L, Xiong Y, et al. Cell-based high-throughput screening of cationic polymers for efficient DNA and siRNA delivery. Acta Biomater. 2020;115:410–417. doi:10.1016/j.actbio.2020.08.029
   PubMed Web of Science ®Google Scholar
• Chuan D, Jin T, Fan R, et al. Chitosan for gene delivery: methods for improvement and applications. Adv Colloid Interface Sci. 2019;268:25–38. doi:10.1016/j.cis.2019.03.007
   PubMed Web of Science ®Google Scholar
• Yang S, Wong KH, Hua P, et al. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy. Acta Biomater. 2022;140:492–505. doi:10.1016/j.actbio.2021.11.042
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liang Q, Wu X, et al. siRNA delivery against myocardial ischemia reperfusion injury mediated by reversibly camouflaged biomimetic nanocomplexes. Adv Mater. 2023;35(23):e2210691. doi:10.1002/adma.202210691
   PubMed Web of Science ®Google Scholar
• Liu F, Sheng S, Shao D. A cationic metal-organic framework to scavenge cell-free DNA for severe sepsis management. Nano Lett. 2021;21(6):2461–2469. doi:10.1021/acs.nanolett.0c04759
   PubMed Web of Science ®Google Scholar
• Charbe NB, Amnerkar ND, Ramesh B, et al. Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Acta Pharm Sin B. 2020;10(11):2075–2109. doi:10.1016/j.apsb.2020.10.005
   PubMed Web of Science ®Google Scholar
• Lin G, Revia RA, Zhang M. Inorganic nanomaterial-mediated gene therapy in combination with other antitumor treatment modalities. Adv Funct Mater. 2021;31(5):2007096. doi:10.1002/adfm.202007096
   PubMed Web of Science ®Google Scholar
• Dai X, Zhao X, Liu Y, et al. Controlled synthesis and surface engineering of janus chitosan-gold nanoparticles for photoacoustic imaging-guided synergistic gene/photothermal therapy. Small. 2021;17(11):e2006004. doi:10.1002/smll.202006004
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao T, Han F, et al. Photothermal and gene therapy combined with immunotherapy to gastric cancer by the gold nanoshell-based system. J Nanobiotechnology. 2019;17(1):80. doi:10.1186/s12951-019-0515-x
   PubMedGoogle Scholar
• Ma X, Liang X, Li Y, et al. Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field. Nat Commun. 2023;14(1):1606. doi:10.1038/s41467-023-37225-1
   PubMed Web of Science ®Google Scholar
• Gong X, Wang H, Li R, et al. A smart multiantenna gene theranostic system based on the programmed assembly of hypoxia-related siRNAs. Nat Commun. 2021;12(1):3953. doi:10.1038/s41467-021-24191-9
   PubMed Web of Science ®Google Scholar
• Liu MX, Xu L, Jiang J-Y. Light controlled self-escape capability of non-cationic carbon nitride-based nanosheets in lysosomes for hepatocellular carcinoma targeting stimulus-responsive gene delivery. Bioeng Transl Med. 2023;8(5):e10558. doi:10.1002/btm2.10558
   PubMed Web of Science ®Google Scholar
• Ma P, Wang Q, Luo X, et al. Recent advances in stimuli-responsive polymeric carriers for controllable CRISPR/Cas9 gene editing system delivery. Biomater Sci. 2023;11(15):5078–5094. doi:10.1039/d3bm00529a
   PubMed Web of Science ®Google Scholar
• Fang T, Cao X, Ibnat M, et al. Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing. J Nanobiotechnology. 2022;20(1):354. doi:10.1186/s12951-022-01570-y
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Delfi M, Zarrabi A, et al. Stimuli-responsive liposomal nanoformulations in cancer therapy: pre-clinical & clinical approaches. J Control Release. 2022;351:50–80. doi:10.1016/j.jconrel.2022.08.001
   PubMed Web of Science ®Google Scholar
• Liang L, Cen H, Huang J, et al. The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy. Mol Cancer. 2022;21(1):186. doi:10.1186/s12943-022-01651-4
   PubMed Web of Science ®Google Scholar
• Chen H, Fan X, Zhao Y, et al. Stimuli-responsive polysaccharide enveloped liposome for targeting and penetrating delivery of survivin-shRNA into breast tumor. ACS Appl Mater Interfaces. 2020;12(19):22074–22087. doi:10.1021/acsami.9b22440
   PubMed Web of Science ®Google Scholar
• Wang Z, Hao D, Wang Y. Peptidyl virus-like nanovesicles as reconfigurable ”trojan horse” for targeted siRNA delivery and synergistic inhibition of cancer cells. Small. 2023;19(1):e2204959. doi:10.1002/smll.202204959
   PubMed Web of Science ®Google Scholar
• Liufu C, Li Y, Tu J, et al. Echogenic PEGylated PEI-loaded microbubble as efficient gene delivery system. Int J Nanomed. 2019;14:8923–8941. doi:10.2147/ijn.s217338
   PubMed Web of Science ®Google Scholar
• Wang Z, Song L, Liu Q, et al. A Tubular DNA Nanodevice as a siRNA/chemo-drug co-delivery vehicle for combined cancer therapy. Angew Chem Int Ed Engl. 2021;60(5):2594–2598. doi:10.1002/anie.202009842
   PubMed Web of Science ®Google Scholar
• Ma Y, Lin H, Wang P, et al. A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma. Acta Biomater. 2023;155:538–553. doi:10.1016/j.actbio.2022.11.016
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng X, Liu J, et al. Tumor-Targeted Anti-VEGF RNAi capable of sequentially responding to intracellular microenvironments for potent systemic tumor suppression. ACS Appl Bio Mater. 2020;3(12):9145–9155. doi:10.1021/acsabm.0c01427
   PubMedGoogle Scholar
• Huang X, Li J, Li G, et al. Cation-free siRNA-cored nanocapsules for tumor-targeted RNAi therapy. Acta Biomater. 2023;161:226–237. doi:10.1016/j.actbio.2023.03.001
   PubMed Web of Science ®Google Scholar
• Shen X, Dirisala A, Toyoda M, et al. pH-responsive polyzwitterion covered nanocarriers for DNA delivery. J Control Release. 2023;360:928–939. doi:10.1016/j.jconrel.2023.07.038
   PubMed Web of Science ®Google Scholar
• Zhang X, Qin B, Wang M, et al. Dual pH-responsive and tumor-targeted nanoparticle-mediated anti-angiogenesis siRNA delivery for tumor treatment. Int J Nanomed. 2022;17:953–967. doi:10.2147/ijn.s340926
   PubMed Web of Science ®Google Scholar
• Wang Y, Xiong X, Zhu Y, et al. A pH-responsive nanoplatform based on fluorescent conjugated polymer dots for imaging-guided multitherapeutics delivery and combination cancer therapy. ACS Biomater Sci Eng. 2022;8(1):161–169. doi:10.1021/acsbiomaterials.1c01244
   PubMed Web of Science ®Google Scholar
• Gong C, Yu X, Zhang W, et al. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles. J Nanobiotechnology. 2021;19(1):58. doi:10.1186/s12951-021-00805-8
   PubMed Web of Science ®Google Scholar
• Qiao H, Zhang L, Fang D, et al. Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles. Chem Sci. 2021;12(12):4547–4556. doi:10.1039/d0sc06680j
   PubMed Web of Science ®Google Scholar
• Li Y, Ding J, Xu X. Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano Lett. 2020;20(7):4857–4863. doi:10.1021/acs.nanolett.0c00757
   PubMed Web of Science ®Google Scholar
• Zhou H, Liao Y, Han X, et al. ROS-responsive nanoparticle delivery of mRNA and photosensitizer for combinatorial cancer therapy. Nano Lett. 2023;23(9):3661–3668. doi:10.1021/acs.nanolett.2c03784
   PubMed Web of Science ®Google Scholar
• Jia X, Lv M, Fei Y, et al. Facile one-step synthesis of NIR-Responsive siRNA-Inorganic hybrid nanoplatform for imaging-guided photothermal and gene synergistic therapy. Biomaterials. 2022;282:121404. doi:10.1016/j.biomaterials.2022.121404
   PubMed Web of Science ®Google Scholar
• Chen L, Li G, Wang X, et al. Spherical nucleic acids for near-infrared light-responsive self-delivery of small-interfering RNA and antisense oligonucleotide. ACS Nano. 2021;15(7):11929–11939. doi:10.1021/acsnano.1c03072
   PubMed Web of Science ®Google Scholar
• Feng Y, Fang J, Zhao Y, et al. NIR light-mediated mitochondrial RNA Modification for Cancer RNA interference therapeutics. Angew Chem Int Ed Engl. 2023;62(19):e202218969. doi:10.1002/anie.202218969
   PubMed Web of Science ®Google Scholar
• Hamner KL, Alexander CM, Coopersmith K, et al. Using temperature-sensitive smart polymers to regulate DNA-mediated nanoassembly and encoded nanocarrier drug release. ACS Nano. 2013;7(8):7011–7020. doi:10.1021/nn402214e
   PubMed Web of Science ®Google Scholar
• Chen C, Ma Y, Du S, et al. Controlled CRISPR-Cas9 ribonucleoprotein delivery for sensitized photothermal therapy. Small. 2021;17(33):e2101155. doi:10.1002/smll.202101155
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang L, Zheng W, et al. Thermo-triggered release of CRISPR-cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy. Angew Chem Int Ed Engl. 2018;57(6):1491–1496. doi:10.1002/anie.201708689
   PubMed Web of Science ®Google Scholar
• Dalmina M, Pittella F, Sierra JA, et al. Magnetically responsive hybrid nanoparticles for in vitro siRNA delivery to breast cancer cells. Mater Sci Eng C Mater Biol Appl. 2019;99:1182–1190. doi:10.1016/j.msec.2019.02.026
   PubMed Web of Science ®Google Scholar
• Du M, Chen Y, Tu J, et al. Ultrasound responsive magnetic mesoporous silica nanoparticle-loaded microbubbles for efficient gene delivery. ACS Biomater Sci Eng. 2020;6(5):2904–2912. doi:10.1021/acsbiomaterials.0c00014
   PubMed Web of Science ®Google Scholar
• Sun W, Ji P, Zhou T, et al. Ultrasound responsive nanovaccine armed with engineered cancer cell membrane and RNA to prevent foreseeable metastasis. Adv Sci (Weinh). 2023;10(19):e2301107. doi:10.1002/advs.202301107
   PubMedGoogle Scholar
• Lu Q, Chen R, Du S, et al. Activation of the cGAS-STING pathway combined with CRISPR-Cas9 gene editing triggering long-term immunotherapy. Biomaterials. 2022;291:121871. doi:10.1016/j.biomaterials.2022.121871
   PubMed Web of Science ®Google Scholar
• Tang H, Xue Y, Li B, et al. Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma. Acta Pharm Sin B. 2022;12(8):3410–3426. doi:10.1016/j.apsb.2022.02.007
   PubMed Web of Science ®Google Scholar
• Liang J, Wu C, Zhou X, et al. Host-guest interaction-based dual response core/shell nanoparticles as efficient siRNA carrier for killing breast cancer cells. Colloids Surf B Biointerfaces. 2021;205:111918. doi:10.1016/j.colsurfb.2021.111918
   PubMed Web of Science ®Google Scholar
• Jing Z, Li Y, Song J, et al. Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes. Int J Biol Macromol. 2023;253(Pt 3):126912. doi:10.1016/j.ijbiomac.2023.126912
   PubMedGoogle Scholar
• Sahoo S, Maiti S, Poddar P, et al. Cationic cross-linked polymers containing labile disulfide and boronic ester linkages for effective triple responsive DNA release. Colloids Surf B Biointerfaces. 2020;191:110988. doi:10.1016/j.colsurfb.2020.110988
   PubMed Web of Science ®Google Scholar
• Deepak KGK, Vempati R, Nagaraju GP, et al. Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res. 2020;153:104683. doi:10.1016/j.phrs.2020.104683
   PubMed Web of Science ®Google Scholar
• Liu J, Chen T, Li S, et al. Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy. Semin Cancer Biol. 2022;86(Pt 2):259–268. doi:10.1016/j.semcancer.2022.06.004
   PubMedGoogle Scholar
• Liu Y, Dong W, Ma Y, et al. Nanomedicines with high drug availability and drug sensitivity overcome hypoxia-associated drug resistance. Biomaterials. 2023;294:122023. doi:10.1016/j.biomaterials.2023.122023
   PubMed Web of Science ®Google Scholar
• Cox TR. The matrix in cancer. Nat Rev Cancer. 2021;21(4):217–238. doi:10.1038/s41568-020-00329-7
   PubMed Web of Science ®Google Scholar
• Tang Q, Sun S, Wang P, et al. Genetically engineering cell membrane-coated BTO nanoparticles for MMP2-activated piezocatalysis-immunotherapy. Adv Mater. 2023;35(18):e2300964. doi:10.1002/adma.202300964
   PubMed Web of Science ®Google Scholar
• Shi J, Ren Y, Ma J, et al. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis. J Nanobiotechnology. 2021;19(1):188. doi:10.1186/s12951-021-00934-0
   PubMed Web of Science ®Google Scholar
• Hengyu L, Tianqi N, Xiao D, et al. Cerebral delivery of redox-responsive lenalidomide prodrug plus methotrexate for primary central nerve system lymphoma combination therapy. J Control Release. 2023;359:132–146. doi:10.1016/j.jconrel.2023.05.040
   PubMed Web of Science ®Google Scholar
• Xia C, Xing X, Zhang W, et al. Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis. Redox Biol. 2023;69:102999. doi:10.1016/j.redox.2023.102999
   PubMed Web of Science ®Google Scholar
• Fu LH, Wan Y, Qi C, et al. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater. 2021;33(7):e2006892. doi:10.1002/adma.202006892
   PubMed Web of Science ®Google Scholar
• Na S, Zhe S, Bo W, et al. Suicide gene delivery by morphology-adaptable enantiomeric peptide assemblies for combined ovarian cancer therapy. Acta Biomater. 2024;175:250–261. doi:10.1016/j.actbio.2023.12.020
   PubMed Web of Science ®Google Scholar
• Elhanani O, Ben-Uri R, Keren L. Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell. 2023;41(3):404–420. doi:10.1016/j.ccell.2023.01.010
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ. Tumor microenvironment, metabolism, and immunotherapy. N Engl J Med. 2020;382(9):869–871. doi:10.1056/NEJMcibr1914890
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang J, Luo R, et al. Stimulus-responsive and dual-target DNA nanodrugs for rheumatoid arthritis treatment. Int J Pharm. 2023;632:122543. doi:10.1016/j.ijpharm.2022.122543
   PubMedGoogle Scholar
• Li D, Ren T, Ge Y, et al. A multi-functional hypoxia/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea. J Nanobiotechnology. 2023;21(1):291. doi:10.1186/s12951-023-02062-3
   PubMed Web of Science ®Google Scholar
• Peng S, Xiao F, Chen M, et al. Tumor-microenvironment-responsive nanomedicine for enhanced cancer immunotherapy. Adv Sci. 2022;9(1):e2103836. doi:10.1002/advs.202103836
   Web of Science ®Google Scholar
• Shen C, Gao M, Chen H, et al. Reactive oxygen species (ROS)-responsive nanoprobe for bioimaging and targeting therapy of osteoarthritis. J Nanobiotechnology. 2021;19(1):395. doi:10.1186/s12951-021-01136-4
   PubMed Web of Science ®Google Scholar
• Jiang Q, Zhang S. Stimulus-responsive drug delivery nanoplatforms for osteoarthritis therapy. Small. 2023;19(23):e2206929. doi:10.1002/smll.202206929
   PubMed Web of Science ®Google Scholar
• Kang W, Liu Y, Wang W. Light-responsive nanomedicine for cancer immunotherapy. Acta Pharm Sin B. 2023;13(6):2346–2368. doi:10.1016/j.apsb.2023.05.016
   PubMed Web of Science ®Google Scholar
• Zhao Y, He P, Yao J, et al. pH/NIR-responsive and self-healing coatings with bacteria killing, osteogenesis, and angiogenesis performances on magnesium alloy. Biomaterials. 2023;301:122237. doi:10.1016/j.biomaterials.2023.122237
   PubMed Web of Science ®Google Scholar
• Sam R, Divanbeigi Kermani M, Ohadi M, et al. Different applications of temperature responsive nanogels as a new drug delivery system mini review. Pharm Dev Technol. 2023;28(5):492–500. doi:10.1080/10837450.2023.2209796
   PubMed Web of Science ®Google Scholar
• Hossain MS, Zhang Z, Ashok S, et al. Temperature-responsive nano-biomaterials from genetically encoded farnesylated disordered proteins. ACS Appl Bio Mater. 2022;5(5):1846–1856. doi:10.1021/acsabm.1c01162
   PubMedGoogle Scholar
• Korpanty J, Wang C, Gianneschi NC. Upper critical solution temperature polymer assemblies via variable temperature liquid phase transmission electron microscopy and liquid resonant soft X-ray scattering. Nat Commun. 2023;14(1):3441. doi:10.1038/s41467-023-38781-2
   PubMed Web of Science ®Google Scholar
• Saranya M, da Silva AM, Karjalainen H, et al. Magnetic-responsive carbon nanotubes composite scaffolds for chondrogenic tissue engineering. Adv Healthc Mater. 2023;12(30):e2301787. doi:10.1002/adhm.202301787
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xue H, Zhang H, et al. Enhanced thrombolytic effect induced by acoustic cavitation generated from nitrogen-doped annealed nanodiamond particles. Ultrason Sonochem. 2023;99:106563. doi:10.1016/j.ultsonch.2023.106563
   PubMed Web of Science ®Google Scholar
• Chen W, He H, Jiao P. Metal-organic framework for hypoxia/ROS/pH triple-responsive cargo release. Adv Healthc Mater. 2023;12(29):e2301785. doi:10.1002/adhm.202301785
   PubMedGoogle Scholar
• Shu M, Tang J, Chen L, et al. Tumor microenvironment triple-responsive nanoparticles enable enhanced tumor penetration and synergetic chemo-photodynamic therapy. Biomaterials. 2021;268:120574. doi:10.1016/j.biomaterials.2020.120574
   PubMed Web of Science ®Google Scholar